CellAxia
Tokyo
About CellAxia
CellAxia is a biotechnology startup that creates medications for cell treatment. Drug discovery bio-venture aiming at the practical application of advanced research such as cell therapy. It serves clients operating in the healthcare sector.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2020)
- Website: cellaxia.co.jp
- Phone: +81 03-3527-2448
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Wellness
Canonical: https://fsome.com/organization/cellaxia-121223 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.